newsfilter
← Latest News
Business Wire·

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)

– Permanent, product-specific J-code facilitates efficient claims and reimbursement – Omeros Corporation (NASDAQ:OMER) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a